/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/cw-stocks-3.png
/assets/img/red-line.jpg
/assets/img/cw-stocks.png
21ьз╕ Cweather-icon
/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/cw-stocks-3.png
/assets/img/red-line.jpg
/assets/img/cw-stocks.png

Promoters to participate in TCS#39; Rs 16,000 crore buyback offer

News2018-06-29
4 Views

Promoters to participate in TCS#39; Rs 16,000 crore buyback offer At the company#39;s 50th annual general meeting in June this year, TCS managing director and CEO Rajesh Gopinathan had said the capital allocation policy is paramount to the company.

Latest News from Moneycontrol.com

Read More..
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.


Hepion Pharmaceuticals' (Nasdaq: HEPA) CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver Disease





/assets/img/wysh-jewels.png

/assets/img/hjli.png

/assets/img/Mars-Parachute-2.png

/assets/img/crweworld-podcast.jpg
Sponsored
Also read